Biomarkers Could Point to Preclampsia Risk
Cedars-Sinai investigators have found that a specific imbalance of two placental proteins could predict preeclampsia risk.
Read MorePosted by Chris Wolski | Nov 11, 2022 | Prenatal Testing |
Cedars-Sinai investigators have found that a specific imbalance of two placental proteins could predict preeclampsia risk.
Read MorePosted by Chris Wolski | Nov 9, 2022 | Tissue Processing |
Scientists at the Ural Federal University (UrFU) have developed a new sensor device for determining cholesterol levels in the blood.
Read MorePosted by Andy Lundin | Nov 8, 2022 | Sequencing Systems |
Tailoring the analysis of whole genome sequencing to individual patients could double the diagnostic rates of rare diseases.
Read MorePosted by Andy Lundin | Nov 2, 2022 | Pancreatic |
Bluestar Genomics announced the results of a validation study for its early pancreatic cancer detection test.
Read MorePosted by Andy Lundin | Nov 1, 2022 | Pancreatic |
Pancreatic cancer could be identified in patients up to three years earlier than current diagnoses, new research suggests.
Read More